Back

Pathophysiology of ATTR and mechanism-based therapeutics

28 August 2026 (15:30 - 15:40)
Organised by: Logo
Congress Presentation Part of: Understanding thick hearts: diagnostic pathways and therapeutic mechanisms Cardiac Amyloidosis Open Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Nitasha Sarswat

University of Chicago Medical Center, Chicago (United States of America)

4 More presentations in this session

Presentation thumbnail
Welcome and introduction
Doctor P. Garcia-Pavia (Majadahonda, ES)
Presentation thumbnail
Clinical context of thick hearts and diagnostic considerations
Doctor P. Garcia-Pavia (Majadahonda, ES)
Presentation thumbnail
Clinical evidence for vutrisiran in transthyretin cardiomyopathy
Professor O. Lairez (Toulouse, FR)
Presentation thumbnail
Understanding thick hearts: diagnostic pathways and therapeutic mechanisms - discussion and Q&A

Access the full session

Session thumbnail
Understanding thick hearts: diagnostic pathways and therapeutic mechanisms

The Event

Event poster

ESC Congress 2026

28 August 2026 15:30 CET
You may be interested in
thumbnail
Congress Session
ACT FAST for ATTR-CM: early clues in heart failure to raise clinical suspicion
17 May 2025
thumbnail
Congress Presentation
Effect of RNAi therapeutics patisiran and vutrisiran on orthostatic hypotension due to dysautonomia in patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy
26 August 2022
thumbnail
Congress Presentation
Next-generation therapeutics
22 May 2023
thumbnail
Congress Session
Evolving treatment paradigms in heart failure: from SGLT2 inhibition to transthyretin stabilisation and beyond
20 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources